Contrast Media Market Trends

  • Report ID: 4917
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Contrast Media Market Trends

Growth Drivers

  • Growing Prevalence of Chronic Diseases – Chronic diseases such as cancer, heart disease, musculoskeletal, and other diseases are the leading causes of death and disability, requiring various imaging modalities for diagnosis and follow-up of treatment. Chronic diseases are estimated at US$ 3.5 trillion annually in the annual health care cost, by the National Center for Prevention and Health Promotion.
  • Increased R & D Investments in Contrast Agents– Projects aimed at developing novel contrast agents and expanding their application are underway by companies, research institutes, and universities all over the world. In 2020, Dr Gang Han, a biochemistry and pharmacology professor at the University of Massachusetts Technology Development Fund received USD 25 000 in seed funding for research into MRI contrast media or gadolinium-based pharmaceuticals with fewer side effects.
  • Growing Application of Contrast Agents in Healthcare –  there is an increase in demand for MRI machines and CT scanners owing to the public preference for accurate and faster diagnostic methods. The market is also estimated to grow owing to the increase in the adoption rate of technologically advanced equipment such as CT scanners, 3D contrast media delivery systems, and syringeless power injectors. The Food and Drug Administration (FDA) recently approved Contrast-Enhanced Ultrasound (CEUS) for radiology procedures.
  • Increasing Product Approvals of Contrast Agents– It is expected that newer product approvals and launches in the field of contrast media drive the market growth in the forecast period. For instance, according to reports, in March 2022, the first single source photon counting CT scanner with one of the detectors received FDA 510k approval. In addition, the OmniTom Elite with PCD will be able to generate sectoral CT images at different energy levels that are expected to stimulate market growth shortly.

Challenges

  • Side effects of contrast agents- The increasing concern amongst individuals for the side effects associated with contrast agents is one of the major factors predicted to slow down the market growth. To perform a variety of medical procedures like MRI and CT scans, the use of contrast agents is not considered unsafe. However, they have a range of side effects, ranging from mild to severe; such as nausea, and vomiting.
  • Lack of skilled professionals
  • Restriction in using gadolinium-based contrast agents

Contrast Media Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

6.8%

Base Year Market Size (2024)

USD 6.86 billion

Forecast Year Market Size (2037)

USD 15.88 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4917
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of contrast media is evaluated at USD 7.23 billion.

The contrast media market size was over USD 6.86 billion in 2024 and is anticipated to exceed USD 15.88 billion by the end of 2037, growing at over 6.8% CAGR during the forecast period i.e., between 2025-2037. Increasing incidences of chronic diseases, and the growing application of contrast agents in healthcare will boost the market growth.

North America is poised to be the largest with a share of about 35% by 2037, attributed to increased funding from government and non-government organizations in the field of biomedical research.

The major players in the market include Bayer AG, General Electric Company, Guerbet, Bracco Diagnostic, Inc., Trivitron Healthcare, Nano Therapeutics Pvt. Ltd., iMax, Lantheus Medical Imaging, Inc., Beijing Beilu Pharmaceuticals Company Limited, SANOCHEMIA Pharmazeutika GmbH.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample